rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2003-9-26
|
pubmed:abstractText |
An impaired ocular hemodynamic response to systemic nitric oxide synthesis inhibition has been demonstrated in patients with long-standing insulin-dependent diabetes mellitus. It is unclear whether this altered responsiveness is already detectable in early uncomplicated type I diabetes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0721-832X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
241
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
619-24
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12836035-Adult,
pubmed-meshheading:12836035-Blood Flow Velocity,
pubmed-meshheading:12836035-Blood Pressure,
pubmed-meshheading:12836035-Case-Control Studies,
pubmed-meshheading:12836035-Cohort Studies,
pubmed-meshheading:12836035-Diabetes Mellitus, Type 1,
pubmed-meshheading:12836035-Dose-Response Relationship, Drug,
pubmed-meshheading:12836035-Enzyme Inhibitors,
pubmed-meshheading:12836035-Eye,
pubmed-meshheading:12836035-Hemodynamics,
pubmed-meshheading:12836035-Humans,
pubmed-meshheading:12836035-Injections, Intravenous,
pubmed-meshheading:12836035-Male,
pubmed-meshheading:12836035-Nitric Oxide Synthase,
pubmed-meshheading:12836035-Ophthalmic Artery,
pubmed-meshheading:12836035-Pulse,
pubmed-meshheading:12836035-Single-Blind Method,
pubmed-meshheading:12836035-Time Factors,
pubmed-meshheading:12836035-omega-N-Methylarginine
|
pubmed:year |
2003
|
pubmed:articleTitle |
The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.
|
pubmed:affiliation |
Department of Clinical Pharmacology, University of Vienna Medical School, Währinger Gürtel 18-20, 1090 Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|